"In the era of increasing health care costs, "network meta‐analysis" and "pharmacoeconomic modeling" are increasingly being used to describe a product's value proposition to reimbursement agencies and decision makers. Our market access experts come together with our sponsors to strategize how these techniques can help them prioritize their research, effective pricing and value communications..."

Dr. Vatsal Shah

Chief Operating Officer



quit
Dr. Rishabh Pandey

Dr. Pandey holds a doctorate in Pharmacology trained at the Indian Institute of Public Health on conducting meta-analysis and health economic evaluations and has also been certified on health technology assessments by the University of Sheffield. He has published & presented more than 30 papers in national/international journals & conferences and reviewed manuscripts for leading publication houses like Elsevier, SAGE, Bentham science, Springer and Informa. His experience spans over a decade including academics, scientific communications and medical information. He has worked on numerous public health, epidemiology, real world evidence, health economics and outcome research projects.

He was part of GSK’s Global Medical Information and Scientific Affairs Department (GMISA) before he began his stint at SIRO. In his +4 years at SIRO, he has worked on more than 60 publications spanning various TAs like oncology, neurosciences, cardiovascular & outcome research for internationally reputed journals and international congresses.

Dr. Rishabh Pandey


Dr. Pandey holds a doctorate in Pharmacology trained at the Indian Institute of Public Health on conducting meta-analysis and health economic evaluations and has also been certified on health technology assessments by the University of Sheffield. He has published & presented more than 30 papers in national/international journals & conferences and reviewed manuscripts for leading publication houses like Elsevier, SAGE, Bentham science, Springer and Informa.

His experience spans over a decade including academics, scientific communications and medical information. He has worked on numerous public health, epidemiology, real world evidence, health economics and outcome research projects.
Read more


quit
Dr. Pandey’s poster focuses on:

  • Comparison of efficacy demonstrated by Statins, NSAIDs, Vitamins, Omega-3-Fatty acids, 5-HT modulators, PBT2 and Xanthene derivatives in Randomised Control Trials
  • The efficacy demonstrated by Statins compared to other classes
  • Simvastatin showing the highest probability of being ranked one

"An indirect comparison of unapproved treatment options of Alzheimer’s disease for research prioritization"


Poster Presentation:

Research on methods studies - Session V
Wednesday, May 24, 2017
Poster display hours: 8:00 – 13:30 EST
Poster discussion hours: 12:30 – 13:30 EST

Several treatment options under investigation, have shown potential of improving prognosis in Alzheimer’s disease. However, evidences have not been sufficient to establish the efficacy and therefore gain a marketing approval. Most of these studies involving these treatment options are placebo-controlled and a huge dearth of comparative evidences is seen.

Through a detailed poster presentation, understand how SIRO experts compared all these potential treatment options indirectly and synthesized efficacy data for research prioritization, bringing to light the most efficacious option!
Read more

quit
Dr. Pandey’s poster focuses on:

  • Although CSII is associated with greater QALYs gained in Indian settings, how expensive it is as compared to MDI
  • Is cost per QALY gained with CSII is greater than thrice of GDP per capita of India?
  • Requirement of quality local data to reduce the uncertainty in estimates

"A cost-effectiveness analysis of continuous subcutaneous insulin infusion vs multiple daily insulin in Indian patients with Type 1 – Diabetes"


Poster Presentation:

Medical Devices & Diagnostics - Session IV
Tuesday, May 23, 2017
Poster display hours: 15:45 – 19:45 EST
Poster discussion hours: 18:45 – 19:45 EST

Diabetes is one of the most prevalent non-communicable diseases in India. Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injection (MDI) both techniques are efficacious in type 1 diabetes. However, CSII is expensive and therefore not preferred by patients in middle income countries like India. SIRO’s poster focuses on a research conducted to compare the cost effectiveness of CSII with MDI in Indian settings.
Read more



SCIENTIFIC WRITING AND PUBLICATIONS

“SIRO drives its wheel of progress in varied arenas of scientific and medical publications with its well-trained, process-compliant, customer-centric team of publication specialists”